title: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?
authors.affiliation: Department of Structural Biology, Federal University of Alfenas, Alfenas, MG, 37130-000, Brazil.
authors.forename: Rômulo Dias
authors.initials: RD
authors.lastname: Novaes
authors.affiliation: Department of Animal Biology, Federal University of Viçosa, Viçosa, MG, 36570-000, Brazil.
authors.forename: Reggiani Vilela
authors.initials: RV
authors.lastname: Gonçalves
authors.affiliation: Department of Pathology and Parasitology, Federal University of Alfenas, Alfenas, MG, 37130-000, Brazil.
authors.forename: Ivo Santana
authors.initials: IS
authors.lastname: Caldas
mesh_terms: D000913:Antibodies, Protozoan; D000941:Antigens; D000953:Antigens, Protozoan / Q000276:immunology; D003429:Cross Reactions; D006801:Humans; D009369:Neoplasms; D014349:Trypanosoma cruzi / Q000276:immunology*; D014612:Vaccines
chemical_list: D000913:Antibodies, Protozoan; D000941:Antigens; D000953:Antigens, Protozoan; D014612:Vaccines